Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Rheumatology and Arthritis Learning Network or HMP Global, their employees, and affiliates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper from tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper from tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Investigators sought to establish the responsiveness to therapy and minimum clinically important improvement for patient-reported outcome measures in psoriatic arthritis.
Investigators sought to establish the responsiveness to therapy and minimum clinically important improvement for patient-reported outcome measures in psoriatic arthritis.
Researchers found differences in life expectancy among patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis. Take our quiz to test your knowledge on the subject!
Researchers found differences in life expectancy among patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis. Take our quiz to test your knowledge on the subject!